Background and Purpose: The purpose of this study is to evaluate whether release of inflammatory markers locally from an atherosclerotic plaque after carotid artery stenting (CAS) is associated with plaque echogenicity and calcification. Methods: The study consisted of 36 patients with 42 severely stenotic carotid arteries who underwent CAS with the distal balloon occlusion. Before CAS, the plaque echogenicity was evaluated by acoustic densitometry and the distribution of calcification was investigated. Systemic blood samples were obtained from the aorta before CAS and local blood samples under distal balloon occlusion just after CAS. Results: The interleukin (IL)-6 and osteopontin (OPN) levels markedly increased at the plaque site in comparison to the systemic values (p < 0.001). Moreover, the local IL-18 level slightly increased compared to the systemic values. In contrast, the local high-sensitive C-reactive protein level slightly decreased. The local matrix metalloproteinase (MMP)-2, tissue inhibitor of MMP-1 and soluble intercellular adhesion molecule 1 levels were not changed. The levels of local IL-6 release were associated with lower echogenicity and less calcification (p < 0.05), while those of local OPN release were independent of plaque characteristics. Conclusions: Our observations show that IL-6 and OPN were released from carotid stenotic lesions after CAS. The association between high levels of IL-6 release and lower plaque echogenicity and less plaque calcification suggests that IL-6 is prone to be released from vulnerable carotid plaques after CAS.

Keywords:
Inflammation, Angioplasty, Carotid stenosis, Interleukins, Carotid ultrasound
1.
Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002;105:1135–1143.
2.
Koenig W, Khuseyinova N: Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol 2007;27:15–26.
3.
Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, Heimovitz H, Cohen HJ, Wallace R: Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999;106:506–512.
4.
Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836–843.
5.
Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000;101:1767–1772.
6.
Blankenberg S, Luc G, Ducimetière P, Arveiler D, Ferrières J, Amouyel P, Evans A, Cambien F, Tiret L, PRIME Study Group: Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2003;108:2453–2459.
7.
Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara E, Ueno T, Sugi K, Imaizumi T: Peripheral blood levels of metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. Am J Cardiol 1998;32:368–372.
8.
Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT, Pinsky DJ, Marmur JD: Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction. Am Heart J 2006;151:1101.e1–1101.e8.
9.
Hwang SJ, Ballantyne CM, Sharret AR, Davis CE, Gotto AM Jr, Boerwhinkle E: Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the atherosclerosis risk in communities (ARIC) study. Circulation 1997;96:4219–4225.
10.
Kato R, Momiyama Y, Ohmori R, Tanaka N, Taniguchi H, Arakawa K, Kusuhara M, Nakamura H, Ohsuzu F: High plasma levels of osteopontin in patients with restenosis after percutaneous coronary intervention. Arterioscler Thromb Vasc Biol 2006;26:e1–e2.
11.
Ohmori R, Momiyama Y, Taniguchi H, Takahashi R, Kusuhara M, Nakamura H, Ohsuzu F: Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 2003;170:333–337.
12.
Choudhary S, Higgins CL, Chen IY, Reardon M, Lawrie G, Vick GW 3rd, Karmonik C, Via DP, Morrisett JD: Quantitation and localization of matrix metalloproteinases and their inhibitors in human carotid endarterectomy tissues. Arterioscler Thromb Vasc Biol 2006;26:2351–2358.
13.
Golledge J, McCann M, Mangan S, Lam A, Karan M: Osteoprotegrin and osteopontin are expressed at high concentration within symptomatic carotid atherosclerosis. Stroke 2004;35:1636–1641.
14.
Krupinski J, Turu MM, Martinez-Gonzalez J, Carvajal A, Juan-Babot JO, Iborra E, Slevin M, Rubio F, Badimon L: Endogenous expression of C-reactive protein is increased in active (ulcerated noncomplicated) human carotid artery plaques. Stroke 2006;37:1200–1204.
15.
Mallat Z, Corbaz A, Scoazec A, Besnard S, Lesèche G, Chvatchko Y, Tedgui A: Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001;104:1598–1603.
16.
Funayama H, Ishikawa S, Kubo N, Katayama T, Yasu T, Saito M, Kawakami M: Increases in interleukin-6 and matrix metalloproteinase-9 in the infarct-related coronary artery of acute myocardial infarction. Circ J 2004;68:451–454.
17.
Ko YG, Jung JH, Park S, Choi E, Joung B, Hwang KC, Ha JW, Choi D, Jang Y, Chung N, Shim WH, Cho SY: Inflammatory and vasoactive factors in the aspirate from the culprit coronary artery of patients with acute myocardial infarction. Int J Cardiol 2006;112:66–71.
18.
Maier W, Altwegg LA, Corti R, Gay S, Hersberger M, Maly FE, Sutsch G, Roffi M, Neidhart M, Eberli FR, Tanner FC, Gobbi S, von Eckardstein A, Luscher TF: Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 2005;111:1355–1361.
19.
Abe Y, Sakaguchi M, Furukado S, Fujinaka T, Sakoda S, Yoshimine T, Kitagawa K: Interleukin-6 release after carotid artery stenting and periprocedural new ischemic lesions. J Cereb Blood Flow Metab 2010;30:857–863.
20.
Nagano K, Yamagami H, Tsukamoto Y, Nagatsuka K, Yasaka M, Nagata I, Hori M, Kitagawa K, Naritomi H: Quantitative evaluation of carotid plaque echogenicity by integrated backscatter analysis. Correlation with symptomatic history and histological findings. Cerebrovasc Dis 2008;26:578–583.
21.
Grønholdt ML, Nordestgaard BG, Schroeder TV, Vorstrup S, Sillesen H: Ultrasonic echolucent carotid plaques predict future strokes. Circulation 2001;104:68–73.
22.
Matheisen EB, Bønaa KH, Joakimsen O: Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the Tromsø study. Circulation 2001;103:2171–2175.
23.
Hashimoto H, Tagaya M, Niki H, Etani H: Computer-assisted analysis of heterogeneity on B-mode imaging predicts instability of asymptomatic carotid plaque. Cerebrovasc Dis 2009;28:357–364.
24.
Yamagami H, Kitagawa K, Nagai Y, Hougaku H, Sakaguchi M, Kuwabara K, Kondo K, Masuyama T, Matsumoto M, Hori M: Higher levels of interleukin-6 are associated with lower echogenicity of carotid artery plaques. Stroke 2004;35:677–668.
25.
Hashimoto H, Kitagawa K, Hougaku H, Shimizu Y, Sakaguchi M, Nagai Y, Iyama S, Yamanishi H, Matsumoto M, Hori M: C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation 2001;104:63–67.
26.
Ehara S, Kobayashi Y, Yoshiyama M, Shimada K, Shimada Y, Fukuda D, Nakamura Y, Yamashita H, Yamagishi H, Takeuchi K, Naruko T, Haze K, Becker AE: Spotty calcification typifies the culprit plaques in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation 2004;110:3424–3429.
27.
Wayhs R, Zelinger A, Raggi P: High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol 2002;39:225–230.
28.
Hunt JL, Fairman R, Mitchell ME, Carpenter JP, Golden M, Khalapyan T, Wolfe M, Neschis D, Milner R, Scoll B, Cusack A, Mohler ER 3rd: Bone formation in carotid plaques; a clinicopathological study. Stroke 2002;33:1214–1219.
29.
Koga M, Kimura K, Minematsu K, Yamaguchi T: Diagnosis of internal carotid artery stenosis greater than 70% with power Doppler duplex sonography. AJNR Am J Neuroradiol 2001;22:413–417.
30.
Rothwell PM, Gibson RJ, Slattery J, Sellar RJ, Warlow CP: Equivalence of measurements of carotid stenosis. A comparison of three methods on 1,001 angiograms. European Carotid Surgery Trialists’ Collaborative Group. Stroke 1994;25:2435–2439.
31.
Shaalan WE, Wahlgren CM, Desai T, Piano G, Skelly C, Bassiouny HS: Reappraisal of velocity criteria for carotid bulb/internal carotid artery stenosis utilizing high-resolution B-mode ultrasound validated with computed tomography angiography. J Vasc Surg 2008;48:104–113.
32.
Takiuchi S, Rakugi H, Honda K, Masuyama T, Hirata N, Ito H, Sugimoto K, Yanagitani Y, Moriguchi K, Okamura A, Higaki J, Ogihara T: Quantitative ultrasonic tissue characterization can identify high-risk atherosclerotic alteration in human carotid arteries. Circulation 2000;102:766–770.
33.
Rus H, Niculescu F: Inflammatory response in unstable angina. Circulation 1999;100:e98.
34.
Nandalur KR, Hardie AD, Raghaven P, Schipper MJ, Baskurt E, Kramer CM: Composition of the stable carotid plaque: insights from a multidetector computed tomography study of plaque volume. Stroke 2007;38:935–940.
35.
Uwatoko T, Toyoda K, Inoue T, Yasumori K, Hirai Y, Makihara N, Fujimoto S, Ibayashi S, Iida M, Okada Y: Carotid artery calcification on multislice detector-row computed tomography. Cerebrovasc Dis 2007;24:20–26.
36.
Packard RR, Libby P: Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 2008;54:24–38.
37.
Scatena M, Liaw L, Giachelli CM: Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007;27:2302–2309.
38.
Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, Tordoir JH, Spronk HM, Vermeer C, Daemen MJ: Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001;21:1998–2003.
39.
Molloy KJ, Thompson MM, Schwalbe EC, Bell PR, Naylor AR, Loftus IM: Comparison of levels of matrix metalloproteinases, tissue inhibitor of metalloproteinases, interleukins, and tissue necrosis factor in carotid endarterectomy specimens from patients on versus not on statins preoperatively. Am J Cardiol 2004;94:144–146.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.